These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 21944048

  • 1. Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer.
    van Heijl M, Phoa SS, van Berge Henegouwen MI, Omloo JM, Mearadji BM, Sloof GW, Bossuyt PM, Hulshof MC, Richel DJ, Bergman JJ, Ten Kate FJ, Stoker J, van Lanschot JJ.
    Eur J Surg Oncol; 2011 Dec; 37(12):1064-71. PubMed ID: 21944048
    [Abstract] [Full Text] [Related]

  • 2. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer.
    van Heijl M, Omloo JM, van Berge Henegouwen MI, Hoekstra OS, Boellaard R, Bossuyt PM, Busch OR, Tilanus HW, Hulshof MC, van der Gaast A, Nieuwenhuijzen GA, Bonenkamp HJ, Plukker JT, Cuesta MA, Ten Kate FJ, Pruim J, van Dekken H, Bergman JJ, Sloof GW, van Lanschot JJ.
    Ann Surg; 2011 Jan; 253(1):56-63. PubMed ID: 21233607
    [Abstract] [Full Text] [Related]

  • 3. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F, Johnsen G, Johnson E, Viste A, Myrnäs T, Szabo E, Jacobsen AB, Friesland S, Tsai JA, Persson S, Lindblad M, Lundell L, Nilsson M.
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [Abstract] [Full Text] [Related]

  • 4. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
    Li SH, Rau KM, Lu HI, Wang YM, Tien WY, Liang JL, Lin WC.
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
    [Abstract] [Full Text] [Related]

  • 5. [18 F]Fluorodeoxyglucose PET/CT and prediction of histopathological response to neoadjuvant chemotherapy for adenocarcinoma of the oesophagus and oesophagogastric junction.
    Harustiak T, Zemanova M, Fencl P, Hornofova L, Pazdro A, Snajdauf M, Salkova E, Lischke R, Stolz A.
    Br J Surg; 2018 Mar; 105(4):419-428. PubMed ID: 29417984
    [Abstract] [Full Text] [Related]

  • 6. Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
    Lorenzen S, von Gall C, Stange A, Haag GM, Weitz J, Haberkorn U, Lordick F, Weichert W, Abel U, Debus J, Jäger D, Münter MW.
    BMC Cancer; 2011 Jun 24; 11():266. PubMed ID: 21702914
    [Abstract] [Full Text] [Related]

  • 7. The value of ¹⁸F-FDG PET/CT in assessment of metabolic response in esophageal cancer for prediction of histopathological response and survival after preoperative chemoradiotherapy.
    Myslivecek M, Neoral C, Vrba R, Vomackova K, Cincibuch J, Formanek R, Koranda P, Zapletalova J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun 24; 156(2):171-9. PubMed ID: 22660205
    [Abstract] [Full Text] [Related]

  • 8. Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.
    Weber MA, Bender K, von Gall CC, Stange A, Grünberg K, Ott K, Haberkorn U, Kauczor HU, Zechmann C.
    J Gastrointestin Liver Dis; 2013 Mar 24; 22(1):45-52. PubMed ID: 23539390
    [Abstract] [Full Text] [Related]

  • 9. (18)F-FDG-PET/CT in assessing response to neoadjuvant chemoradiotherapy for potentially resectable locally advanced esophageal cancer.
    Metser U, Rashidi F, Moshonov H, Wong R, Knox J, Guindi M, Darling G.
    Ann Nucl Med; 2014 May 24; 28(4):295-303. PubMed ID: 24474598
    [Abstract] [Full Text] [Related]

  • 10. ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography for Evaluating the Response to Neoadjuvant Chemotherapy in Advanced Esophageal Cancer.
    Tani Y, Nakajima M, Kikuchi M, Ihara K, Muroi H, Takahashi M, Domeki Y, Okamoto K, Yamaguchi S, Sasaki K, Tsuchioka T, Sakamoto S, Kato H.
    Anticancer Res; 2016 Jan 24; 36(1):367-73. PubMed ID: 26722067
    [Abstract] [Full Text] [Related]

  • 11. Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer.
    Piessen G, Petyt G, Duhamel A, Mirabel X, Huglo D, Mariette C.
    Ann Surg; 2013 Jul 24; 258(1):66-76. PubMed ID: 23470576
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of CT examination in assessing the response of oesophageal carcinoma to neoadjuvant chemotherapy.
    Krupski W, Pasławski M, Złomaniec J, Ciechański A, Dabrowski A.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Jul 24; 58(1):333-7. PubMed ID: 15315010
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
    Noordman BJ, Spaander MCW, Valkema R, Wijnhoven BPL, van Berge Henegouwen MI, Shapiro J, Biermann K, van der Gaast A, van Hillegersberg R, Hulshof MCCM, Krishnadath KK, Lagarde SM, Nieuwenhuijzen GAP, Oostenbrug LE, Siersema PD, Schoon EJ, Sosef MN, Steyerberg EW, van Lanschot JJB, SANO study group.
    Lancet Oncol; 2018 Jul 24; 19(7):965-974. PubMed ID: 29861116
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer.
    Motoyama S, Sato Y, Sasaki T, Wakita A, Kawakita Y, Liu J, Nagaki Y, Saito H, Imai K, Konno H, Mizusawa KT, Minamiya Y.
    Anticancer Res; 2017 Oct 24; 37(10):5837-5843. PubMed ID: 28982909
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.